SCHEMBL7425979

SCHEMBL7425979

CCCNc1ccc(OC)c(OC2CCc3ccccc32)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.43
PDE4A P27815 2/20 0.42
PDE4B Q07343 2/20 0.42
PDE4C Q08493 2/20 0.42
PDE4D Q08499 2/20 0.42
NOX1 Q9Y5S8 1/20 0.41
DRD2 P14416 3/20 0.40
DRD4 P21917 2/20 0.40
DRD3 P35462 2/20 0.40
SMPD1 P17405 1/20 0.40
PIN1 Q13526 1/20 0.39
HTR1A P08908 2/20 0.39
MEN1 O00255 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
HTR5A P47898 1/20 0.39
KMT2A Q03164 1/20 0.39
IDO1 P14902 2/20 0.39
ACHE P22303 1/20 0.39
BACE1 P56817 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4637327 0.76 FFAR1 (0.43) PDE4APDE4BPDE4CPDE4DNOX1
SCHEMBL3821707 0.74 MAPT (0.53) MEN1CYP1A2KMT2AKDM4EALDH1A1
SCHEMBL4637286 0.74 ALDH1A1 (0.51) PDE4APDE4BPDE4CPDE4DNOX1
SCHEMBL7425987 0.74 SMPD1 (0.47) SMPD1IDO1KDM4E
SCHEMBL7533615 0.72 IDO1 (0.38) DRD2DRD4DRD3HTR1AMEN1
SCHEMBL8707317 0.70 NR1H3 (0.51) PDE4APDE4BPDE4CPDE4DNOX1
SCHEMBL15136802 0.70 PDE4A (0.60) NPC1PDE4APDE4BPDE4CPDE4D
SCHEMBL4637258 0.70 PDE4A (0.55) PDE4APDE4BPDE4CPDE4D
SCHEMBL12320927 0.69 AR (0.47) PDE4APDE4BPDE4CPDE4DNOX1
SCHEMBL7424982 0.68 ALDH1A1 (0.51) PDE4APDE4BPDE4CPDE4DDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0874819-A1 IMIDES AS PDE III, PDE IV AND TNF INHIBITORS CELGENE CORPORATION (US) 1998-11-04 EP disclosed
WO-1997023457-A1 IMIDES AS PDE III, PDE IV AND TNF INHIBITORS CELGENE CORPORATION (US) 1997-07-03 WO disclosed